Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma
Clinical trial NCT00101101 · COMPLETED
Trial details
- NCT number
- NCT00101101
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2012-10-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.